446829-41-0Relevant articles and documents
HEPATITIS C VIRUS ENTRY INHIBITORS
-
Page/Page column 84, (2010/11/30)
The present invention relates to the use of tricyclic diphenylamine derivative compounds for prevention and/or treatment of Hepatitis C virus (HCV) infection by inhibiting HCV entry into permissive cells.
CARBAZOLE DERIVATIVES FOR TREATING POLYCYSTIC KIDNEY DISEASE
-
Page/Page column 77-78, (2010/10/19)
Compounds represented by Structural Formula (I): where X is -H, -OR, -SH, -OC(O)R, -OC(O)OR,-OC(O)NRR or -SC(O)OR have anti-cystogenic activity, particularly against polycystic kidney disease. Such compounds can be used in pharmaceutical compounds and in